PG
Procter & GambleNYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-05-08
As of May 8, 2026, PG has a composite score of 14.7, categorized as "mild favorable." This score is influenced by a medium confidence level of 71.2 and a low risk label, with strengths in management (72.8) and quality (70.8). The score reflects various factors, including macroeconomic conditions and sector trends, but the analysis is provisional.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.13
- Bonus0.00
Why this rank
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $1.53 → $1.42 (-6.8% / 30d). 0 raised, 15 cut, 17 covering analysts.
0 upgrades, 0 downgrades / 30d, 7 maintained. 58% of analysts rate Buy.
6 PT revisions / 30d. Avg target 10.2% above current price.
0 positive, 0 negative / 30d.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
4 material events in the last 24 months — top 4 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Maintain sales growth guidancegrowthmixed40% progress
4/24: “P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year.”
Why this status
Stated in 3 of last 3 quarters. Revenue increased from $20.225B in 2025-Q4 to $22.386B in 2026-Q1, then slightly decreased to $22.208B in 2026-Q2. The trajectory shows mixed results, with a slight decline in the latest quarter.
- 2.Sustain EPS growth outlookgrowthmixed55% progress
4/24: “P&G maintained its outlook for fiscal 2026 diluted net earnings per share growth to be in the range of one percent to six percent.”
Why this status
Stated in 3 of last 3 quarters. EPS was $1.95 in 2026-Q1 and decreased to $1.78 in 2026-Q2. The trajectory shows a decline in EPS, indicating limited progress towards the growth outlook.
- 3.Achieve high free cash flow productivitycapital allocationwatchprovisional
10/24: “P&G continues to expect adjusted free cash flow productivity of 85% to 90%.”
Why this status
Newly stated in 2025-Q1. Cash from operating activities was $10.38B in 2026-Q2, indicating strong cash generation. However, without specific free cash flow productivity metrics, the trajectory remains unclear.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 21%; 252d 18%.
Drawdown — Max 1y −18%. Bad day move −2%.
Beta to sector ETF (XLP) — 1.02 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 70/100, drawdown 65/100, beta 98/100, earnings vol —.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Maintain sales growth guidance
GrowthNew since 2026-05-04P&G aims to maintain its guidance for fiscal 2026 all-in sales growth between 1% and 5%.
MixedStated in 3 of last 3 quarters. Revenue increased from $20.225B in 2025-Q4 to $22.386B in 2026-Q1, then slightly decreased to $22.208B in 2026-Q2. The trajectory shows mixed results, with a slight decline in the latest quarter.
40%CEO/CFO:“P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year.”Multiple sourcesSource dated 2026-04-24Stated 3 of last 8 quartersFirst seen 2026-05-04Show history (3)
- 2026-Q2Multiple sources
“P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year.”
- 2026-Q1Multiple sources
“P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year.”
- 2025-Q4Multiple sources
“P&G expects fiscal year 2026 all-in sales growth in the range of one to five percent versus the prior year.”
- #2
Sustain EPS growth outlook
GrowthNew since 2026-05-04P&G aims to sustain its EPS growth outlook for fiscal 2026, targeting a range of 1% to 6% growth.
MixedStated in 3 of last 3 quarters. EPS was $1.95 in 2026-Q1 and decreased to $1.78 in 2026-Q2. The trajectory shows a decline in EPS, indicating limited progress towards the growth outlook.
55%CEO/CFO:“P&G maintained its outlook for fiscal 2026 diluted net earnings per share growth to be in the range of one percent to six percent.”Multiple sourcesSource dated 2026-04-24Stated 3 of last 8 quartersFirst seen 2026-05-04Show history (3)
- 2026-Q2Multiple sources
“P&G maintained its outlook for fiscal 2026 diluted net earnings per share growth to be in the range of one percent to six percent.”
- 2026-Q1Multiple sources
“P&G maintained its fiscal 2026 core earnings per share growth to be in the range of in-line to up four percent.”
- 2025-Q4Multiple sources
“P&G expects fiscal 2026 diluted net earnings per share growth in the range of 3% to 9%.”
- #3
Achieve high free cash flow productivity
Capital allocationNew since 2026-05-04P&G aims to achieve adjusted free cash flow productivity of 85% to 90% for fiscal 2026.
WatchNewly stated in 2025-Q1. Cash from operating activities was $10.38B in 2026-Q2, indicating strong cash generation. However, without specific free cash flow productivity metrics, the trajectory remains unclear.
Cash from operating activities was $10.38B in 2026-Q2No scoreCEO/CFO:“P&G continues to expect adjusted free cash flow productivity of 85% to 90%.”Multiple sourcesSource dated 2025-10-24Stated 1 of last 8 quartersFirst seen 2026-05-04provisionalShow history (1)
- 2025-Q1Multiple sources
“P&G continues to expect adjusted free cash flow productivity of 85% to 90%.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks more expensive than peers.
Cheaper than its own typical valuation.
P/E over the last 5 years
56 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
PG Procter & Gamble | +15 | fair | low |
WMT Walmart | -9.3 | expensive | low |
COST Costco | +3.9 | expensive | moderate |
KO Coca-Cola Company (The) | +14 | full | low |
PM Philip Morris International | +5.0 | full | moderate |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If consumer_staples sector trend rises from +0.05 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently REAFFIRMED as of 2026-04-24)+4.0 pts
- If next-quarter guidance is cut (currently REAFFIRMED as of 2026-04-24)-8.0 pts
- If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.2 pts
- If consumer_staples sector trend falls from +0.05 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-2414d agoItem 2.02
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 24, 2026 , The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended March 31, 2026. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."
earnings preannouncementneutralscore 47 - 2026-04-1424d agoItem 7.01
REGULATION FD DISCLOSURE On April 14, 2026, The Procter & Gamble Company (the "Company") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0885 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2026, to Common Stock shareholders of record at the close of business on April 24, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock…
capital allocationneutralscore 30 - 2026-01-223mo agoItem 2.02
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 22, 2026 , The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended December 31, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."
earnings preannouncementneutralscore 6 - 2026-01-133mo agoItem 7.01
REGULATION FD DISCLOSURE On January 13, 2026, The Procter & Gamble Company (the "Company") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2026, to Common Stock shareholders of record at the close of business on January 23, 2026, and to Series A and Series B ESOP Convertible Class A Prefer…
capital allocationneutralscore 4 - 2025-12-154mo agoItem 5.02
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its beh…
executive changeneutralscore 3
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.